New Content  edit
Get The App!

An Interactive CME-Certified Symposium

Real-World Data and the Management of ICH in Anticoagulated Patients

An Interactive CME-Certified Symposium

Thursday, 25 May 2023
13:15 – 14:45 CEST
Munich, Germany

ICM-International Congress Center Messe München
81829 Munich, Germany
Room 5, Ground Floor

Online registration is now closed. Please come directly to the event.
We look forward to your participation!

This satellite symposium will be conducted during the ESOC Congress. Not an official event of the ESO Conference. Not sponsored or endorsed by ESO.

Symposium Overview

A patient presents with acute left-sided weakness, direct oral anticoagulants (DOAC) on board and a suspected intracranial hemorrhage (ICH). This neurological emergency requires immediate action and smart decisions. Will you distinguish life-threatening from minor bleeding? Should you use repletion or specific reversal therapy? Are you prepared to supplement existing guidelines with emerging real-world evidence?

Join an international panel of renowned stroke specialists to explore these questions through didactic and case-based presentations as well as audience involvement. Don’t miss an information-packed symposium that promises to enhance clinical practice and improve ICH outcomes at your institution!


Natalie Kreitzer, MD, MS

Associate Professor of Emergency Medicine
Department of Emergency Medicine
University of Cincinnati College of Medicine
Director of Stroke Services
West Chester Hospital
Cincinnati, USA

David Seiffge, MD

Professor of Neurology
Department of Neurology
Inselspital University Hospital Bern
University of Bern
Bern, Switzerland

Adrian R. Parry-Jones, MD, FRCP, PhD

Geoffrey Jefferson Brain Research Centre
University of Manchester
Manchester, UK


W. Brian Gibler, MD, FACEP, FACC, FAHA

University of Cincinnati College of Medicine
Cincinnati, USA

Full Accreditation and Program Information


Welcome & Introductions
Repletion or Reversal? Optimizing Specific Therapy for Direct Oral Anticoagulant (DOAC)-Related Life-Threatening Bleeding Using Real-World Experience - Dr. Natalie Kreitzer
Panel Discussion: Repletion Management for Vitamin K Antagonist Anticoagulation
Reversal of Factor Xa Inhibitor ICH: ANNEXA-4, ANNEXA-I and Real-World Evidence - Dr. David Seiffge
Panel Discussion: Specific Reversal Therapy for Factor Xa and Factor IIa Inhibitor-Associated ICH Life-Threatening Bleeding
Development of a Critical Care Pathway for Patients with ICH Using Specific Reversal Agents for Anticoagulated Patients with ICH - Dr. Adrian Parry-Jones
Panel Discussion: Reinforcement of Principles, Overcoming Treatment Barriers, and Improving Time to Treatment for ICH
Audience Q&A
Symposium Ends

Target Audience

This activity has been designed to meet the educational needs of the interprofessional team, including neurologists, neurointensivists, critical care specialists, emergency medicine, clinical cardiologists, hospital medicine, radiologists, neurosurgery, nurse practitioners, physician assistants, nurses, pharmacists as well as other clinicians involved in the management of patients with intracranial hemorrhages (ICH).

Learning Objectives

After completing this activity, the participant should be better able to:

  • Employ appropriate treatment management strategies to address the critical clinical aspects of ICH and hematoma expansion
  • Explain when and how to initiate appropriate reversal agents in ICH bleeds
  • Discuss the need to develop and implement protocols and local care pathways based upon on existing evidence-based medicine guidelines to improve the management of ICH bleeds

Accreditation Information

Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Global Learning Collaborative (GLC) and TotalCME, Inc. GLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credits for learning and change.

Fee Information : There is no fee for this educational activity.

Participants will be invited to complete an evaluation form at the end of the event. A statement of credit will be issued upon receipt of the evaluation form. If you are a registered user of MedEd On The Go, you will receive a certificate in your online bank immediately upon completion. If you complete a paper form, a certificate will be manually processed and emailed to you.

Supported by an educational grant from AstraZeneca.
Jointly provided by the Global Learning Collaborative (GLC), EMCREG-International, and TotalCME, Inc.